Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 132 results for "glaxo arm glaxo india"

GSK spends $1.05 bn to raise stake in Indian arm

GlaxoSmithKline Plc (GSK) yesterday said that it has paid £625 million ($1.05 billion) to increase its stake in its Indian subsidiary GSK Pharmaceuticals to 75 per cent, as the British pharmaceutical giant bets on future growth prospects of its ... Domain-B, 1 month ago
GSK Pharma open offer gets oversubscribed Business Standard India, 1 month ago

74 images for glaxo arm glaxo india

Financial Express, 2 days ago
NDTV Profit, 2 weeks ago
Find Law, 3 weeks ago
Orlando Sentinel, 3 weeks ago
1440 WNFL, 3 weeks ago, 3 weeks ago
4 Traders, 3 weeks ago
Reuters, 3 weeks ago
Reuters, 3 weeks ago
BDlive, 1 week ago

Govt clears GlaxoSmithKline's Rs.6,400 crore FDI proposal

After the purchase, holding of the promoter group firm in the Indian subsidiary will go up to 75% from the current level of 50.67%. Photo: Hemant Mishra/Mint New Delhi: The government on Thursday cleared Rs. 6,400 crore foreign direct investment ...
 Livemint.com1 month ago Govt clears GSKs Rs 6400 crore FDI proposal  Big News Network1 month ago Govt clears GlaxoSmithKlines FDI proposal  The Hindu1 month ago Govt clears GlaxoSmithKline's Rs 6,400 cr FDI proposal  Business Standard1 month ago

GSK lifts emerging market bet with full control of Indonesia arm

1:43pm GMT LONDON, March 28 (Reuters) - GlaxoSmithKline is betting more on Indonesia by taking full control of its consumer healthcare unit in the country, underscoring a drive by the drugmaker to build up its presence in fast-growing emerging ...
 Reuters UK3 weeks ago STOCKS NEWS EUROPE-AIM index higher, Optare jumps in heavy trade  London South East3 weeks ago GSK lifts EM bet with full control of Indonesia arm  Moneycontrol.com3 weeks ago GlaxoSmithKline : GSK lifts emerging market bet with full control of Indonesia arm  4 Traders3 weeks ago

State-run insurers may stay out of GlaxoSmithKline's open offer

NEW DELHI: State-run financial institutions , of India and Oriental Insurance are unlikely to take part in UK drug maker GlaxoSmithKline's ongoing open offer to shareholders of its Indian subsidiary GlaxoSmithKline Pharmaceuticals. The three ...
 Economic Times1 month ago

AstraZeneca Pharma India board approves delisting offer

The board of directors of AstraZeneca Pharma India Ltd, the domestic-listed arm of British-Swedish drug maker, has approved voluntary open offer to delist the company, according to a stock market disclosure. The delisting proposal received from ...
 VC Circle1 month ago AstraZeneca's Indian arm asks for more information from parent on delisting offer  VC Circle1 month ago AstraZeneca seeks to delist Indian arm  VC Circle1 month ago

GSK ups stake in Indian arm via open offer

2. Comments that are abusive, personal, incendiary or irrelevant cannot be published. 3. Please write complete sentences. Do not type comments in all capital letters, or in all lower case letters, or using abbreviated text. (example: u cannot substitute for ...
 The Hindu1 month ago
Business Standard India

Tender GSK shares in open offer: Analysts

The GlaxoSmithKline Pharma (GSK Pharma) stock, which has been on the rise since mid-December (when its foreign parent announced plans to raise its stake in the company), hit an all-time high of Rs 3,054.4 on Monday. Though it shed some gains on ...
 Sify1 month ago Open offer keeps GSK Pharma healthy  Hindu Business Line1 month ago Tender GSK Pharma shares in open offer: Analysts  Business Standard India1 month ago
Business Standard India

No immediate cure for GSK Pharma's ailments

GlaxoSmithKline Pharma's December quarter performance is below expectation as the company continues to grapple with pricing policy, trade related disturbances and supply constraints. The company, which is ranked number six as per latest IMS data, ...
 Business Standard India2 months ago No immediate cure for GSK's ailments  Business Standard India2 months ago

GSK Pharmaceuticals posts 16% drop in December quarter profit

MUMBAI -- GlaxoSmithKline Pharmaceuticals Ltd posted a 16% drop in December-quarter net profit to Rs.117 crore, even as its UK-based parent GlaxoSmithKline Plc began its Rs.6,400 crore buyback of shares in the Indian arm. Sales declined 4% to ...
 MedCity News2 months ago

Nifty attains one-week closing high

Key benchmark indices jumped after government bond prices surged after the Reserve Bank of India (RBI) today, 17 April 2014, fully sold the Rs 20000-crore worth of debt on offer, accomplishing the country's biggest-ever auction. The barometer index, ...
 Business Standard India3 days ago Sensex bounces back after 3-day slide  Business Standard India3 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less